BASECARE Medical Device
Stage
IPO | IPOTotal Raised
$35.11MDate of IPO
1/18/2021About BASECARE Medical Device
BASECARE Medical Device (02170.HK) is a high-tech enterprise committed to researching and developing products used for the clinical field of reproductive health. The PGS (Pre-implantation Genetic Screening) kit independently developed by BASECARE is used for finding embryos with chromosome aneuploidies and/or microdeletion/microduplication, then screening the best quality embryo(s) for transferring to the uterus. The company focuses on providing solutions for reproductive health, helping reduce the rate of birth defects while promoting the popularization and clinical application of PGS/PGD technology in China.
Missing: BASECARE Medical Device's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: BASECARE Medical Device's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing BASECARE Medical Device
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BASECARE Medical Device is included in 4 Expert Collections, including Women's Health & Wellness.
Women's Health & Wellness
1,487 items
Startups focused on providing products and services catering to women's health and wellbeing.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Digital Health
12,724 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Health IT
7,901 items
Latest BASECARE Medical Device News
Feb 8, 2021
China: CanSino Biologics Inc, Kuaishou Technology, Alibaba Group, Tencent Holdings, Sinotruk Hong Kong, Basecare Medical Device, Ping An Insurance (H), China Longyuan Power Group Corp, Joinn Laboratories China Co-A, Sciclone Pharmaceuticals, Inc and more Key Topics in this News Article: News Snapshot: Internet users increased 9.5% in China in 2020. Shanghai Police prosecuted 14 Renren (RENN) employees for piracy of TV series. Tiktok indicted Tencent (700 HK) for monopoly. Bilibili has invested in 33 cartoon producers in the past 12 months. By Victoria Li Heavy-duty truck demand from infrastructure might slow down in 2021E, but demand increase from logistics, which contributed 74% of annual HDT sales, would remain strong in next few years. Also, Sinotruk’s new logistic trucks and newly introduced Weichai engines are boosting its market share. We believe Sinotruk’s earnings will grow by another 10-15% yoy in 2021E after a...
BASECARE Medical Device Frequently Asked Questions (FAQ)
Where is BASECARE Medical Device's headquarters?
BASECARE Medical Device's headquarters is located at A3 Biobay Building, 218 Xinghu Street Suzhou Industrial Park, Suzhou.
What is BASECARE Medical Device's latest funding round?
BASECARE Medical Device's latest funding round is IPO.
How much did BASECARE Medical Device raise?
BASECARE Medical Device raised a total of $35.11M.
Who are the investors of BASECARE Medical Device?
Investors of BASECARE Medical Device include Juming Ventures, Broad Vision Funds, Yingtan Jinhu, Genesis Capital, Darui Biotechnology and 5 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.